Variant report
Variant | nsv969234 |
---|---|
Chromosome Location | chr5:91862074-91866671 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536189101 | chr5:91862074-91862075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35514767 | chr5:91862106-91862107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555381759 | chr5:91862114-91862115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368306239 | chr5:91862115-91862116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145358736 | chr5:91862116-91862117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181692183 | chr5:91862117-91862118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149189684 | chr5:91862245-91862246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577716308 | chr5:91862335-91862336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376692786 | chr5:91862405-91862406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540059488 | chr5:91862448-91862449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559978509 | chr5:91862456-91862457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377670110 | chr5:91862474-91862475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370016185 | chr5:91862497-91862498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529133697 | chr5:91862504-91862505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548892979 | chr5:91862656-91862657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561930439 | chr5:91862657-91862658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185820703 | chr5:91862691-91862692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372281532 | chr5:91862729-91862730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535029459 | chr5:91862797-91862798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191552524 | chr5:91862798-91862799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111706591 | chr5:91862812-91862813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547201546 | chr5:91862815-91862816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182872145 | chr5:91862844-91862845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536154013 | chr5:91862883-91862884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565589348 | chr5:91862891-91862892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556137161 | chr5:91862960-91862961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139326698 | chr5:91863023-91863024 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537850150 | chr5:91863024-91863025 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141995793 | chr5:91863027-91863028 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72779042 | chr5:91863088-91863089 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs537595842 | chr5:91863097-91863098 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539970156 | chr5:91863250-91863251 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535010708 | chr5:91863264-91863265 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559892315 | chr5:91863276-91863277 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187944749 | chr5:91863292-91863293 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148864692 | chr5:91863319-91863320 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564007952 | chr5:91863331-91863332 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542475384 | chr5:91863346-91863347 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562805794 | chr5:91863372-91863373 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs56213708 | chr5:91863378-91863379 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs114674603 | chr5:91863410-91863411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368809700 | chr5:91863461-91863462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371509250 | chr5:91863482-91863483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564357773 | chr5:91863489-91863490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533443989 | chr5:91863490-91863491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs61336224 | chr5:91863493-91863494 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs190631316 | chr5:91863507-91863508 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373825291 | chr5:91863535-91863536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529518713 | chr5:91863554-91863555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549363719 | chr5:91863563-91863564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:91854600-91864200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr5:91855000-91862200 | Weak transcription | NHDF-Ad | bronchial |
3 | chr5:91862200-91862400 | Enhancers | NHDF-Ad | bronchial |
4 | chr5:91862400-91862800 | Weak transcription | NHDF-Ad | bronchial |
5 | chr5:91862600-91862800 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr5:91862600-91864400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr5:91862800-91863000 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr5:91862800-91863800 | Enhancers | HSMMtube | muscle |
9 | chr5:91862800-91863800 | Enhancers | Osteobl | bone |
10 | chr5:91862800-91864400 | Enhancers | NHDF-Ad | bronchial |
11 | chr5:91863000-91863400 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
12 | chr5:91863000-91863400 | Enhancers | Ovary | ovary |
13 | chr5:91863000-91863600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr5:91863000-91864200 | Enhancers | HSMM | muscle |
15 | chr5:91863000-91864400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
16 | chr5:91863400-91864200 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr5:91864200-91864400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |